No Data
Here's How Much $1000 Invested In Krystal Biotech 5 Years Ago Would Be Worth Today
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
A Closer Look at 11 Analyst Recommendations For Crinetics Pharmaceuticals
Arcellx Analyst Ratings
Avidity Biosciences Says Data Suggest Del-zota Has Potential To Change Treatment Paradigm And Course Of Disease For Patients With Duchenne Muscular Dystrophy Mutations Amenable To Exon 44 Skipping
Arcellx GAAP EPS of -$0.51, Revenue of $27.38M